These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31884663)

  • 1. Mitochondrial Gymnastics in Retinal Cells: A Resilience Mechanism Against Oxidative Stress and Neurodegeneration.
    Mirra S; Marfany G
    Adv Exp Med Biol; 2019; 1185():513-517. PubMed ID: 31884663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.
    Yu-Wai-Man P; Griffiths PG; Chinnery PF
    Prog Retin Eye Res; 2011 Mar; 30(2):81-114. PubMed ID: 21112411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial optic neuropathies: how two genomes may kill the same cell type?
    Carelli V; La Morgia C; Iommarini L; Carroccia R; Mattiazzi M; Sangiorgi S; Farne' S; Maresca A; Foscarini B; Lanzi L; Amadori M; Bellan M; Valentino ML
    Biosci Rep; 2007 Jun; 27(1-3):173-84. PubMed ID: 17479363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders.
    Carelli V; La Morgia C; Valentino ML; Barboni P; Ross-Cisneros FN; Sadun AA
    Biochim Biophys Acta; 2009 May; 1787(5):518-28. PubMed ID: 19268652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited mitochondrial optic neuropathies.
    Yu-Wai-Man P; Griffiths PG; Hudson G; Chinnery PF
    J Med Genet; 2009 Mar; 46(3):145-58. PubMed ID: 19001017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.
    Lopez Sanchez MI; Crowston JG; Mackey DA; Trounce IA
    Pharmacol Ther; 2016 Sep; 165():132-52. PubMed ID: 27288727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies.
    La Morgia C; Ross-Cisneros FN; Sadun AA; Hannibal J; Munarini A; Mantovani V; Barboni P; Cantalupo G; Tozer KR; Sancisi E; Salomao SR; Moraes MN; Moraes-Filho MN; Heegaard S; Milea D; Kjer P; Montagna P; Carelli V
    Brain; 2010 Aug; 133(Pt 8):2426-38. PubMed ID: 20659957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete penetrance in mitochondrial optic neuropathies.
    Caporali L; Maresca A; Capristo M; Del Dotto V; Tagliavini F; Valentino ML; La Morgia C; Carelli V
    Mitochondrion; 2017 Sep; 36():130-137. PubMed ID: 28716668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of endoplasmic reticulum stress in rotenone-induced leber hereditary optic neuropathy model and the discovery of new therapeutic agents.
    Aoyama Y; Inagaki S; Aoshima K; Iwata Y; Nakamura S; Hara H; Shimazawa M
    J Pharmacol Sci; 2021 Oct; 147(2):200-207. PubMed ID: 34384568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neurodegenerative perspective on mitochondrial optic neuropathies.
    Yu-Wai-Man P; Votruba M; Burté F; La Morgia C; Barboni P; Carelli V
    Acta Neuropathol; 2016 Dec; 132(6):789-806. PubMed ID: 27696015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment strategies for inherited optic neuropathies: past, present and future.
    Yu-Wai-Man P; Votruba M; Moore AT; Chinnery PF
    Eye (Lond); 2014 May; 28(5):521-37. PubMed ID: 24603424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches.
    Chun BY; Rizzo JF
    Semin Pediatr Neurol; 2017 May; 24(2):129-134. PubMed ID: 28941528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Approaches to Inherited Optic Neuropathies.
    Yu-Wai-Man P
    Semin Neurol; 2015 Oct; 35(5):578-86. PubMed ID: 26444403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hereditary optic atrophies].
    Scherer C; Procaccio V; Ferre M; Guillet V; Reynier P; Amati-Bonneau P; Dubas F; Bonneau D; Verny C
    Rev Neurol (Paris); 2010 Dec; 166(12):959-65. PubMed ID: 21056443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion Tensor Imaging Mapping of Brain White Matter Pathology in Mitochondrial Optic Neuropathies.
    Manners DN; Rizzo G; La Morgia C; Tonon C; Testa C; Barboni P; Malucelli E; Valentino ML; Caporali L; Strobbe D; Carelli V; Lodi R
    AJNR Am J Neuroradiol; 2015 Jul; 36(7):1259-65. PubMed ID: 25792533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant optic atrophy: updates on the pathophysiology and clinical manifestations of the optic atrophy 1 mutation.
    Chun BY; Rizzo JF
    Curr Opin Ophthalmol; 2016 Nov; 27(6):475-480. PubMed ID: 27585216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of Mitochondrial Optic Neuropathies: From Inherited to Acquired Forms.
    Pilz YL; Bass SJ; Sherman J
    J Optom; 2017; 10(4):205-214. PubMed ID: 28040497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bipolar cell reduction precedes retinal ganglion neuron loss in a complex 1 knockout mouse model.
    Song L; Yu A; Murray K; Cortopassi G
    Brain Res; 2017 Feb; 1657():232-244. PubMed ID: 28027875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LHON and other optic nerve atrophies: the mitochondrial connection.
    Howell N
    Dev Ophthalmol; 2003; 37():94-108. PubMed ID: 12876832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of retinal ganglion cell death in Leber hereditary optic neuropathy (LHON): possible involvement of mitochondria, light and glutamate.
    Beretta S; Ferrarese C; Wood JP; Osborne NN; Carelli V
    Mitochondrion; 2006 Apr; 6(2):102-3. PubMed ID: 16581312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.